These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice. Amirshahrokhi K; Dehpour AR; Hadjati J; Sotoudeh M; Ghazi-Khansari M Toxicol Appl Pharmacol; 2008 Oct; 232(1):119-24. PubMed ID: 18671992 [TBL] [Abstract][Full Text] [Related]
25. Partial protection of 1 alpha-hydroxyvitamin D3 against the development of diabetes induced by multiple low-dose streptozotocin injection in CD-1 mice. Inaba M; Nishizawa Y; Song K; Tanishita H; Okuno S; Miki T; Morii H Metabolism; 1992 Jun; 41(6):631-5. PubMed ID: 1386401 [TBL] [Abstract][Full Text] [Related]
26. Preventative effects of the flowers of Inula britannica on autoimmune diabetes in C57BL/KsJ mice induced by multiple low doses of streptozotocin. Kobayashi T; Song QH; Hong T; Kitamura H; Cyong JC Phytother Res; 2002 Jun; 16(4):377-82. PubMed ID: 12112297 [TBL] [Abstract][Full Text] [Related]
27. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo. Sternesjö J; Welsh N; Sandler S Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135 [TBL] [Abstract][Full Text] [Related]
28. The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocin-treated mice persists if essential fatty acid repletion occurs outside of a brief window of susceptibility. Wright JR; Haliburton B; Russell H; Henry M; Fraser R; Cook HW Diabetologia; 1991 Oct; 34(10):709-14. PubMed ID: 1835705 [TBL] [Abstract][Full Text] [Related]
29. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Like AA; Rossini AA Science; 1976 Jul; 193(4251):415-7. PubMed ID: 180605 [TBL] [Abstract][Full Text] [Related]
30. Streptozotocin induced diabetes in minipig: a case report of a possible model for type 1 diabetes? Rolandsson O; Haney MF; Hagg E; Biber B; Lernmark A Autoimmunity; 2002 Jul; 35(4):261-4. PubMed ID: 12482194 [TBL] [Abstract][Full Text] [Related]
31. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice. Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360 [TBL] [Abstract][Full Text] [Related]
32. Anti-interleukin 2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice. Hatamori N; Yokono K; Hayakawa M; Taki T; Ogawa W; Nagata M; Hari J; Shii K; Taniguchi H; Baba S Diabetologia; 1990 May; 33(5):266-71. PubMed ID: 2142923 [TBL] [Abstract][Full Text] [Related]
34. Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice. Wright JR; Lefkowith JB; Schreiner G; Lacy PE Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6137-41. PubMed ID: 3045812 [TBL] [Abstract][Full Text] [Related]
35. [Early induction of diabetes in NOD mice by streptozotocin]. Orlow S; Yasunami R; Boitard C; Bach JF C R Acad Sci III; 1987; 304(3):77-8. PubMed ID: 2949801 [TBL] [Abstract][Full Text] [Related]
36. Development of low-dose streptozotocin-induced diabetes in ICAM-1-deficient mice. Martin S; Vinke A; Heidenthal E; Schulte B; van den Engel N Horm Metab Res; 1999 Dec; 31(12):636-40. PubMed ID: 10668914 [TBL] [Abstract][Full Text] [Related]
37. A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice. Rosenberg L; Lipsett M; Yoon JW; Prentki M; Wang R; Jun HS; Pittenger GL; Taylor-Fishwick D; Vinik AI Ann Surg; 2004 Nov; 240(5):875-84. PubMed ID: 15492571 [TBL] [Abstract][Full Text] [Related]
38. Intramuscular injection of interleukin-10 plasmid DNA prevented autoimmune diabetes in mice. Zhang ZL; Shen SX; Lin B; Yu LY; Zhu LH; Wang WP; Luo FH; Guo LH Acta Pharmacol Sin; 2003 Aug; 24(8):751-6. PubMed ID: 12904273 [TBL] [Abstract][Full Text] [Related]
39. Is Lipotoxicity presents in the early stages of an experimental model of autoimmune diabetes? Further studies in the multiple low dose of streptozotocin model. Karabatas L; Oliva ME; Dascal E; Hein GJ; Pastorale C; Chicco A; Lombardo YB; Basabe JC Islets; 2010; 2(3):190-9. PubMed ID: 21099313 [TBL] [Abstract][Full Text] [Related]
40. Morphological changes in the endocrine pancreas of mice after treatment with streptozotocin combined with cyclophosphamide and neurotropin. Jablenska R; Popova P; Guencheva G; Duhault J; Lesourd M; Petkov P Cell Mol Biol; 1991; 37(6):575-83. PubMed ID: 1836158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]